Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis: an overview.

Rebecca Berke1, Arshdeep Singh, Mark Guralnick

  • 1Kaiser Permanente's Woodland Hills Family Medicine Residency Program, Woodland Hills, CA, USA. Rebecca.g.berke@kp.org

American Family Physician
|September 12, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory bowel disease must be a policy priority after the 2025 United Nations declaration on non-communicable diseases and mental health.

Journal of Crohn's & colitis·2026
Same author

Lipogenesis-driven EGFR palmitoylation enables metastatic immune evasion in triple-negative breast cancer.

bioRxiv : the preprint server for biology·2026
Same author

Exploring role of therapeutic plasma exchange for hepatitis A-related acute liver failure: An Indian multi-center cohort study.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Exclusive enteral nutrition for induction of remission in Crohn's disease in adults: A systematic review and meta-analysis of randomized trials and real-world studies.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis.

Scientific reports·2026
Same author

Prevalence, clinical significance and predictors of small intestinal bacterial overgrowth and elevated fecal calprotectin in refractory irritable bowel syndrome: Insights from a prospective cross-sectional study.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Atopic dermatitis (AD) management focuses on symptom relief and preventing flare-ups. Key treatments include emollients, topical corticosteroids, and calcineurin inhibitors for moderate to severe cases.

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Atopic dermatitis (AD), or atopic eczema, is a prevalent chronic skin condition in the US, affecting millions and causing significant morbidity.
  • Accurate diagnosis and severity grading are crucial for effective patient management.

Purpose of the Study:

  • To outline diagnostic criteria and management strategies for atopic dermatitis.
  • To review current pharmacologic and alternative treatment options for AD.

Main Methods:

  • Utilized simplified diagnostic criteria based on the U.K. Working Party's guidelines.
  • Reviewed established and emerging treatment modalities for AD, including topical corticosteroids, calcineurin inhibitors, and antibiotics.
  • Assessed the evidence for alternative therapies.

Related Experiment Videos

Main Results:

  • Regular emollient use is recommended for symptom relief and preventing flare-ups.
  • Topical corticosteroids are the primary pharmacologic treatment; once-daily application is as effective as more frequent use.
  • Calcineurin inhibitors (pimecrolimus, tacrolimus) are effective second-line options for moderate to severe AD, despite a boxed warning regarding potential risks.
  • Antibiotics treat secondary infections but do not prevent AD flares.
  • Evidence for alternative therapies remains inconclusive.

Conclusions:

  • Effective management of atopic dermatitis involves a multi-faceted approach including symptom control, flare-up prevention, and appropriate pharmacologic interventions.
  • Topical corticosteroids and calcineurin inhibitors are key treatments, while the role of alternative therapies requires further investigation.